热门资讯> 正文

Tenax Therapeutics任命新首席财务官

2026-04-22 19:18

Tenax Therapeutics (TENX) appointed Thomas R. Staab II as CFo, effective May 11, 2026, replacing interim CFO Thomas McGauley.
Staab brings more than 25 years of financial leadership experience in the healthcare sector. He most recently served as CFO and secretary at LENSAR.
Tenax (TENX) also announced inducement equity awards tied to the appointment, including 10,000 restricted stock units and options to purchase 450,000 common shares

More on Tenax Therapeutics

Tenax Therapeutics: A Binary Bet With Heavy Downside Likely
Tenax Therapeutics: Some Future Potential
Tenax wins bullish view at Cantor ahead of pivotal readout
Seeking Alpha’s Quant Rating on Tenax Therapeutics
Historical earnings data for Tenax Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。